FI20075028A0 - Menetelmä ihmisen immuunikatoviruksen havaitsemiseksi - Google Patents
Menetelmä ihmisen immuunikatoviruksen havaitsemiseksiInfo
- Publication number
- FI20075028A0 FI20075028A0 FI20075028A FI20075028A FI20075028A0 FI 20075028 A0 FI20075028 A0 FI 20075028A0 FI 20075028 A FI20075028 A FI 20075028A FI 20075028 A FI20075028 A FI 20075028A FI 20075028 A0 FI20075028 A0 FI 20075028A0
- Authority
- FI
- Finland
- Prior art keywords
- detection
- immunodeficiency virus
- human immunodeficiency
- human
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/161—HIV-1, HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- AIDS & HIV (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Ecology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20075028A FI120376B (fi) | 2007-01-17 | 2007-01-17 | Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi |
PCT/FI2008/050012 WO2008087254A2 (en) | 2007-01-17 | 2008-01-17 | Method for detection of human immunodeficiency virus |
AU2008206881A AU2008206881A1 (en) | 2007-01-17 | 2008-01-17 | Method for detection of human immunodeficiency virus |
JP2009545963A JP2010516660A (ja) | 2007-01-17 | 2008-01-17 | ヒト免疫不全ウイルスの検出方法 |
CA002675122A CA2675122A1 (en) | 2007-01-17 | 2008-01-17 | Method for detection of human immunodeficiency virus |
CN200880002505A CN101646944A (zh) | 2007-01-17 | 2008-01-17 | 检测人免疫缺陷病毒的方法 |
US12/522,838 US20100048407A1 (en) | 2007-01-17 | 2008-01-17 | Method for detection of human immunodeficiency virus |
EP08701712A EP2109772A4 (en) | 2007-01-17 | 2008-01-17 | METHOD FOR DETECTING HUMAN IMMUNE DISEASE VIRUS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20075028A FI120376B (fi) | 2007-01-17 | 2007-01-17 | Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi |
FI20075028 | 2007-01-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI20075028A0 true FI20075028A0 (fi) | 2007-01-17 |
FI20075028L FI20075028L (fi) | 2008-07-18 |
FI120376B FI120376B (fi) | 2009-09-30 |
Family
ID=37745720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20075028A FI120376B (fi) | 2007-01-17 | 2007-01-17 | Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100048407A1 (fi) |
EP (1) | EP2109772A4 (fi) |
JP (1) | JP2010516660A (fi) |
CN (1) | CN101646944A (fi) |
AU (1) | AU2008206881A1 (fi) |
CA (1) | CA2675122A1 (fi) |
FI (1) | FI120376B (fi) |
WO (1) | WO2008087254A2 (fi) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO314588B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV |
US6818392B2 (en) * | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
US6833441B2 (en) * | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
-
2007
- 2007-01-17 FI FI20075028A patent/FI120376B/fi not_active IP Right Cessation
-
2008
- 2008-01-17 AU AU2008206881A patent/AU2008206881A1/en not_active Abandoned
- 2008-01-17 CA CA002675122A patent/CA2675122A1/en not_active Abandoned
- 2008-01-17 US US12/522,838 patent/US20100048407A1/en not_active Abandoned
- 2008-01-17 WO PCT/FI2008/050012 patent/WO2008087254A2/en active Application Filing
- 2008-01-17 JP JP2009545963A patent/JP2010516660A/ja active Pending
- 2008-01-17 CN CN200880002505A patent/CN101646944A/zh active Pending
- 2008-01-17 EP EP08701712A patent/EP2109772A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20100048407A1 (en) | 2010-02-25 |
EP2109772A4 (en) | 2010-09-29 |
CA2675122A1 (en) | 2008-07-24 |
AU2008206881A1 (en) | 2008-07-24 |
JP2010516660A (ja) | 2010-05-20 |
EP2109772A1 (en) | 2009-10-21 |
WO2008087254A2 (en) | 2008-07-24 |
FI120376B (fi) | 2009-09-30 |
CN101646944A (zh) | 2010-02-10 |
WO2008087254A8 (en) | 2009-07-30 |
FI20075028L (fi) | 2008-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR16C1026I1 (fr) | Inhibiteurs de la replication du virus de l'hepatite c | |
CY2015012I1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
DK3329772T3 (da) | Dobbeltvektor til inhibering af human immundefektvirus | |
BRPI1010774A2 (pt) | método de uso de particulados. | |
HUE062860T2 (hu) | Magas koncentrációjú gyógyszerészeti készítmények | |
EP2663857A4 (en) | METHOD OF DETECTION OF PROTEINS | |
FI20095553A0 (fi) | Jätteenkäsittelyjärjestelmä ja menetelmä | |
BRPI1007836A2 (pt) | Inibidores do vírus c da hepatite | |
BRPI1008846A2 (pt) | inibidores do vírus da hepatite c | |
BRPI1013393A2 (pt) | inibidores do vírus da hepatite c | |
BRPI1014084A2 (pt) | inibidores do vírus da hepatite c | |
BRPI0924304A2 (pt) | transportador de classificação | |
DK2245027T3 (da) | Hepatitis C-virusinhibitorer | |
BR112012005438A2 (pt) | inibidores de vírus flaviviridae | |
IL225853A0 (en) | Inhibitors of hepatitis c virus | |
BRPI0922913A2 (pt) | Análogos cíclicos de peptídeo 4-amino-4-oxobutanoil inibidores de replicação viral | |
EP2267119A4 (en) | PROCESS FOR VIRUS ENRICHMENT | |
FI20125113A (fi) | Monimoottorilaitteisto ja menetelmä tämän käyttämiseksi | |
FI20096371A0 (fi) | Mutageneesi menetelmä | |
BRPI0912692A2 (pt) | imunomodulação através de inibidores de iap | |
FI20096354A0 (fi) | Yksityiskohtien prosessoinnin taso | |
BR112014003556A2 (pt) | método de tratamento de vírus, e, composição farmacêutica | |
EP2786145A4 (en) | MELITTIN PEPTIDE CONJUGATES AND THESE USES | |
FI20095352A0 (fi) | Menetelmä ja järjestely kunnonvalvontaan | |
DK2293810T3 (da) | Muteret tat-oyi-protein til forebyggelse eller behandling af aids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120376 Country of ref document: FI |
|
MM | Patent lapsed |